ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is installed...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. The company's lead cell therapy asset is NXC-201 in multiple myeloma...
CLICK TO LEARN MOREEfficacy and Safety Profile of Once-Daily Vemlidy Demonstrated in Children Six Years of Age (Weighing at Least 25kg) and Older FOSTER CITY, Calif. / Mar 28, 2024 / Business Wire / Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has...Read more
MONTREAL and CHARLOTTE, N.C., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the resubmission of its New Drug Application...Read more
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access DUBLIN, March 27, 2024 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the United States Food and Drug...Read more
Collaborative Study involving the VA and UCSD achieved statistically significant decrease in PCS and PTSD symptoms versus control group The data supports the Company’s strategy to offer military and civilian physicians a new tool to effectively treat mTBI without the use of...Read more
Topline Results For Progression-Free Survival Expected In Q2 2024 CARDIFF, UK / ACCESSWIRE / March 28, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) ("Biodexa"), an acquisition-focused biopharmaceutical company, is developing MTX110 for the treatment of Diffuse Midline Glioma (DMG)...Read more
Conducted initial pivotal study interactions with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA); Company has clear registration path for 4D-710 for treatment of cystic fibrosis (CF) lung disease in people with CF (pwCF) who are ineligible for or cannot...Read more
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORECompany | Change | Last Trade |
---|---|---|
Atrion | 19.40 4.33 | $467.41 |
Avalo Therapeutics | 17.81 374.95 | $22.56 |
Inspire Medical Systems | 7.21 3.38 | $220.71 |
ZIVO Bioscience | 6.15 559.09 | $7.25 |
Madrigal Pharmaceuticals | 5.97 2.31 | $264.78 |
ICON | 4.75 1.44 | $334.25 |
ICU Medical | 4.72 4.59 | $107.61 |
ShockWave Medical | 4.52 1.40 | $327.13 |
Exact Sciences | 4.32 6.46 | $71.20 |
Encompass Health | 4.08 5.25 | $81.79 |
Eli Lilly | 4.05 0.52 | $782.23 |
Corbus Pharmaceuticals | 3.90 10.96 | $39.47 |
Korro Bio | 3.83 4.33 | $92.36 |
Celcuity | 3.51 19.33 | $21.67 |
Outlook Therapeutics | 3.10 33.08 | $12.47 |
SIGA Technologies | 3.02 55.51 | $8.47 |
Teleflex | 2.66 1.19 | $226.53 |
Company | Volume | Last Trade |
---|---|---|
Biodexa Pharmaceuticals | 83,512,256 | $1.47 |
Gamida Cell | 74,892,664 | $0.04 |
Akebia Therapeutics | 53,364,026 | $1.80 |
iBio | 46,553,895 | $4.43 |
Ontrak | 31,616,653 | $0.68 |
Jaguar Health | 31,203,085 | $0.08 |
Xilio Therapeutics | 29,546,197 | $1.45 |
Kintara Therapeutics | 29,154,590 | $0.10 |
Pfizer | 23,800,429 | $27.96 |
Walgreens Boots Alliance | 23,501,630 | $21.74 |
Avalo Therapeutics | 22,820,946 | $22.56 |
Ginkgo Bioworks | 19,832,091 | $1.17 |
OPKO Health | 19,764,216 | $1.20 |
Tonix Pharmaceuticals | 16,567,310 | $0.22 |
Mesoblast | 12,500,670 | $4.92 |
Therapeutic Solutions | 8,944,469 | $0.0009 |
Roivant | 8,678,950 | $10.47 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORECOPYRIGHT ©2023 HEALTH STOCKS HUB